Evidence map›Paper›PMID 33052341›Full record

ArticlebioRxiv : the preprint server for biology2020

Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors.

Michael Mor, Michal Werbner, Joel Alter, Modi Safra, Elad Chomsky, Smadar Hada-Neeman, Ksenia Polonsky, Cameron J Nowell, Alex E Clark, Anna Roitburd-Berman and 17 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 10 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 2 countries.

Michael MorDepartment for Microbiology and Clinical Immunology, Faculty of Medicine, Tel Aviv University, Israel.
Michal WerbnerAzrieli Faculty of Medicine, Bar Ilan University, 2800123, Israel.
Joel AlterAzrieli Faculty of Medicine, Bar Ilan University, 2800123, Israel.
Modi SafraFaculty of Engineering, Bar Ilan University, 5290002, Israel.
Elad ChomskyImmunAi, USA.
Smadar Hada-NeemanGeorge S Weiss, Life sciences Faculty, Tel Aviv University, 699780, Israel.
Ksenia PolonskyDepartment for Microbiology and Clinical Immunology, Faculty of Medicine, Tel Aviv University, Israel.
Cameron J NowellMonash Institute of Pharmaceutical Sciences, Parkville, Victoria 3052, Australia.
Alex E ClarkDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA 92093 USA.
Anna Roitburd-BermanGeorge S Weiss, Life sciences Faculty, Tel Aviv University, 699780, Israel.
Noam Ben ShalomDepartment for Microbiology and Clinical Immunology, Faculty of Medicine, Tel Aviv University, Israel.
Michal NavonDepartment for Microbiology and Clinical Immunology, Faculty of Medicine, Tel Aviv University, Israel.
Dor RafaelDepartment for Microbiology and Clinical Immunology, Faculty of Medicine, Tel Aviv University, Israel.
Hila SharimImmunAi, USA.
Evgeny KinerImmunAi, USA.
Eric GriffisNikon Imaging Center, UC San Diego, CA, 92093 USA.
Jonathan M GershoniGeorge S Weiss, Life sciences Faculty, Tel Aviv University, 699780, Israel.
Oren KobilerDepartment for Microbiology and Clinical Immunology, Faculty of Medicine, Tel Aviv University, Israel.
Sandra Lawrynowicz LeibelDepartment of Pediatrics, School of Medicine, UC San Diego, La Jolla, CA 92093 USA.
Oren ZimhonyInfectious Diseases unit, Kaplan Medical Center, Rehovot, 7610001, affiliated to the School of Medicine Hebrew University and Hadassah, Israel.
Aaron F CarlinDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA 92093 USA.
Gur YaariFaculty of Engineering, Bar Ilan University, 5290002, Israel.
Moshe DassauAzrieli Faculty of Medicine, Bar Ilan University, 2800123, Israel.
Meital Gal-TanamyAzrieli Faculty of Medicine, Bar Ilan University, 2800123, Israel.
David HaginDepartment of Immunology Ichilov Hospital, 623906, Israel.
Ben A CrokerDepartment of Pediatrics, School of Medicine, UC San Diego, La Jolla, CA 92093 USA.
Natalia T FreundDepartment for Microbiology and Clinical Immunology, Faculty of Medicine, Tel Aviv University, Israel.
Tel Aviv University · ILBar-Ilan University · ILUniversity of California San Diego · USImmunai (United States) · USKaplan Medical Center · ILNikon (United States) · USRebecca Sieff Hospital · IL

Funding

Defining the roles of RIPK1 and RIPK3 in emergency hematopoiesisR01HL124209 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CROKER, BEN ADAM · 2015 to 2019
$2.2M
NHLBI NIH HHS R01 HL124209
6 · The paper itself

Abstract

The interactions between antibodies, SARS-CoV-2 and immune cells contribute to the pathogenesis of COVID-19 and protective immunity. To understand the differences between antibody responses in mild

Identifiers

PMID33052341
PMCPMC7553166
OpenAlexW3092535655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.